Sort by
Refine Your Search
-
following things we are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis
-
at risk of developing type 1 or type 2 diabetes. The Thurmond Lab is also examining Doc2b as a potential biomarker for diabetes. If this protein can help us detect early diabetic changes, patients can
-
studies (focusing on both basic and translational research). The ultimate goal of the laboratory is to translate the laboratory discoveries into the development and application of effective novel
-
for collecting and handling specimens; ensure proper labeling and obtain pertinent clinical and protocol information on request forms; develop and maintain knowledge of various aspects of processing specimens
-
-edge research. A Staff Scientist position is available for a highly talented bioinformatics engineer to join our computational microbiome team. The successful candidate will contribute to the development
-
pioneering the development of neural stem cell (NSC) and extracellular vesicle (EV)-based therapies for neurodegenerative conditions, including traumatic brain injury (TBI), chemotherapy-related cognitive
-
candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA methylation
-
program and its educational offerings. You will serve as a project manager, navigating the regulatory review process for each of their research studies, ushering manuscripts thru the submission and revision
-
for collecting and handling specimens; ensure proper labeling and obtain pertinent clinical and protocol information on request forms; develop and maintain knowledge of various aspects of processing specimens
-
successful candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA